SEARCH:   Advanced

Blood, Vol. 112, Issue 4, 1515-1521, August 15, 2008 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells Blood Gatza et al. 112: 1515 Supplemental materials for: Gatza et al Files in this Data Supplement: Table S1. Total numbers of donor cells, and the percent and number of CD4+CD25+Foxp3+ cells observed in the spleen, MLN and thymus in ECP treated and control mice post-BMT (PDF, 25.5 KB) Figure S1. ECP treatment schema (JPG, 44.1 KB) - (Top) Mice to receive treatment infusions were transplanted on day 0 as described in “Materials and Methods.” 30 × 106 splenocytes from a second cohort of B6 → C3H.SW BMT recipients (transplanted 14 days earlier) were isolated, exposed to 8-MOP and UVA ex vivo and infused i.v. into the first cohort of BMT recipients 7 days after BMT. Similarly, the first cohort of mice received 2nd, 3rd and 4th infusions of ECP treated cells 14, 21 and 28 days after transplant. (Bottom) Phenotype of B6 → C3H.SW ECP treated splenocytes was determined by flow cytometry prior to infusion. Data is combined from 6 independent cohorts of donor spleens. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020